Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials
- PMID: 22400970
- PMCID: PMC3317394
- DOI: 10.1089/tmj.2011.0116
Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials
Abstract
Background and purpose: Telemedicine can disseminate vascular neurology expertise and optimize recombinant tissue plasminogen activator (rt-PA) use for acute ischemic stroke in rural underserved communities. The purpose of this study was to prospectively assess whether telemedicine or telephone was superior for decision-making.
Methods: The study design is a pooled analysis of two identically designed randomized controlled trials conducted in a multistate hub and spoke telestroke network setting with acute stroke syndrome patients, comparing telemedicine versus telephone-only consultations. From each trial, common data elements were pooled to assess, principally, for correctness of thrombolysis decision-making. Secondary outcomes included rt-PA use rate, 90-day functional outcome, post-thrombolysis intracranial hemorrhage, and data completeness.
Results: Two hundred seventy-six pooled patients were evaluated. Correct thrombolysis eligibility decisions were made more often with telemedicine (96% telemedicine, 83% telephone; odds ratio [OR] 4.2; 95% confidence interval [CI] 1.69-10.46; p=0.002). Intravenous rt-PA usage was 26% (29% telemedicine, 24% telephone; OR 1.27; 95% CI 0.71-2.25; p=0.41). Ninety-day outcomes were not different for Barthel Index, modified Rankin Scale, or mortality. There was no difference in post-thrombolysis intracranial hemorrhage (8% telemedicine, 6% telephone; p>0.999).
Conclusions: This pooled analysis supports the hypothesis that stroke telemedicine consultations, compared with telephone-only, result in more accurate decision-making. Together with high rt-PA utilization rate, low post-rt-PA intracranial hemorrhage rate, and acceptable patient outcome, the results confirm that telemedicine is a viable consultative tool for acute stroke. The replication of the hub and spoke network infrastructure supports the generalizability of telemedicine when used in broader settings.
Trial registration: ClinicalTrials.gov NCT00283868 NCT00623350.
Figures
References
-
- Kleindorfer D. Xu Y. Moomaw CJ. Khatri P. Adeoye O. Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke. 2009;40:3580–3584. - PubMed
-
- Albright K. Martin-Schild S. Morales M. Grotta J. Comment on US geographic distribution of recombinant tissue plasminogen activator use by hospitals for acute ischemic stroke. Stroke. 2010;41:e189. - PubMed
-
- Miley ML. Demaerschalk BM. Olmstead NL. Kiernan TE. Corday DA. Chikani V, et al. The state of emergency stroke resources and care in rural Arizona: A platform for telemedicine. Telemed J E Health. 2009;15:691–699. - PubMed
-
- Wang S. Bae Lee S. Pardue C. Ramsingh D. Waller J. Gross H, et al. Remote evaluation of acute ischemic stroke: Reliability of National Institutes of Health Stroke Scale via telestroke. Stroke. 2003;34:E188–E191. - PubMed
-
- Meyer BC. Lyden PD. Al-Khoury L. Cheng Y. Raman R. Fellman R. Beer J. Rao R. Zivin JA. Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology. 2005;64:1058–1060. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical